BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2108114)

  • 1. The effect of mafenide on dihydropteroate synthase.
    Eagon RG; McManus AT
    J Antimicrob Chemother; 1990 Jan; 25(1):25-9. PubMed ID: 2108114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphanilic acid inhibits dihydropteroate synthase.
    Eagon RG; McManus AT
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1936-8. PubMed ID: 2514624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-Aminobenzoic acid derivatives as inhibitors of the cell-free H2-pteroate synthesizing system of Escherichia coli.
    Thijssen HH
    J Med Chem; 1977 Feb; 20(2):233-6. PubMed ID: 319235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of dihydropteroate synthase: substituent effects in the side-chain aromatic ring of 6-[[3-(aryloxy)propyl]amino]-5-nitrosoisocytosines and synthesis and inhibitory potency of bridged 5-nitrosoisocytosine-p-aminobenzoic acid analogues.
    Lever OW; Bell LN; Hyman C; McGuire HM; Ferone R
    J Med Chem; 1986 May; 29(5):665-70. PubMed ID: 3486292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships in dihydropteroate synthase inhibition by sulfanilamides. Comparison with the antibacterial activity.
    De Benedetti PG; Rastelli A; Frassineti C; Cennamo C
    J Med Chem; 1981 Apr; 24(4):454-7. PubMed ID: 7021831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative structure-activity analysis in dihydropteroate synthase inhibition by sulfones. Comparison with sulfanilamides.
    De Benedetti PG; Iarossi D; Menziani C; Caiolfa V; Frassineti C; Cennamo C
    J Med Chem; 1987 Mar; 30(3):459-64. PubMed ID: 3546688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of omega-(4-aminophenylsulfonamido)alkyl disulfides and thiosulfates and their activity against dihydropteroate synthetase from sulfanilamide-resistant Neisseria gonorrhoeae.
    Foye WO; Kauffman JM; Suttimool W
    J Pharm Sci; 1982 Jul; 71(7):799-802. PubMed ID: 6811724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of different plasmid-borne dihydropteroate synthases mediating bacterial resistance to sulfonamides.
    Swedberg G; Sköld O
    J Bacteriol; 1980 Apr; 142(1):1-7. PubMed ID: 6989796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfa drugs strike more than once.
    Patel OG; Mberu EK; Nzila AM; Macreadie IG
    Trends Parasitol; 2004 Jan; 20(1):1-3. PubMed ID: 14700578
    [No Abstract]   [Full Text] [Related]  

  • 10. R-factor-mediated resistance to sulfonamides by a plasmid-borne, drug-resistant dihydropteroate synthase.
    Sköld O
    Antimicrob Agents Chemother; 1976 Jan; 9(1):49-54. PubMed ID: 769673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Pneumocystis carinii dihydropteroate synthetase by para-acetamidobenzoic acid: possible mechanism of action of isoprinosine in human immunodeficiency virus infection.
    Kovacs JA; Powell F; Voeller D; Allegra CJ
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1227-31. PubMed ID: 7687120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of sulfonamide and sulfone compounds with Toxoplasma gondii dihydropteroate synthase.
    Allegra CJ; Boarman D; Kovacs JA; Morrison P; Beaver J; Chabner BA; Masur H
    J Clin Invest; 1990 Feb; 85(2):371-9. PubMed ID: 2298911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of 5% mafenide acetate solution on bacterial control in infected rat burns.
    Murphy RC; Kucan JO; Robson MC; Heggers JP
    J Trauma; 1983 Oct; 23(10):878-81. PubMed ID: 6415293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Pneumocystis carinii dihydropteroate synthetase by sulfa drugs.
    Merali S; Zhang Y; Sloan D; Meshnick S
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1075-8. PubMed ID: 2203302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity of sulfones and sulfonamides on dihydropteroate synthetase from Neisseria meingitidis.
    Ho RI; Corman L; Mores SA; Schneider H
    Antimicrob Agents Chemother; 1975 Jun; 7(6):758-63. PubMed ID: 808157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydropteroate synthase from Streptococcus pneumoniae: characterization of substrate binding order and sulfonamide inhibition.
    Vinnicombe HG; Derrick JP
    Biochem Biophys Res Commun; 1999 May; 258(3):752-7. PubMed ID: 10329458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyclic pteridine analogues. Inhibition of Escherichia coli dihydropteroate synthase by 6-amino-5-nitrosoisocytosines.
    Lever OW; Bell LN; McGuire HM; Ferone R
    J Med Chem; 1985 Dec; 28(12):1870-4. PubMed ID: 3906132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-Aminobenzoic acid derivatives. Mode of action and structure-activity relationships in a cell-free system (Escherichia coli).
    Seydel JK; Butte W
    J Med Chem; 1977 Mar; 20(3):439-47. PubMed ID: 321779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of Pneumocystis carinii dihydropteroate synthase with sulfonamides and diaminodiphenyl sulfone (dapsone).
    Voeller D; Kovacs J; Andrawis V; Chu E; Masur H; Allegra C
    J Infect Dis; 1994 Feb; 169(2):456-9. PubMed ID: 8106784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of mutationally altered dihydropteroate synthase and its ability to form a sulfonamide-containing dihydrofolate analog.
    Swedberg G; Castensson S; Sköld O
    J Bacteriol; 1979 Jan; 137(1):129-36. PubMed ID: 368012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.